期刊文献+

宫颈康凝胶治疗人乳头瘤病毒感染宫颈炎的临床研究 被引量:4

Therapeutic Efficacy of Gongjingkang gel in Treating Cervicitis Complicated with HPV Infection
原文传递
导出
摘要 目的分析宫颈康凝胶治疗宫颈炎合并人乳头瘤病毒(HPV)感染的临床疗效。方法选择我院妇科门诊确诊的宫颈炎合并HPV感染患者125例,按随机双盲对照法分为三组,宫颈康组(50例)采用宫颈康凝胶;保妇康组(45例)采用保妇康凝胶;空白对照组(30例)采用空白凝胶分别阴道给药治疗,对检测结果进行统计学分析。结果 HPV疗效队列为宫颈康组(82.00%)>保妇康组(71.11%)>空白对照组(13.33%);宫颈炎疗效队列为宫颈康组(84.00%)>保妇康组(68.89%)>空白对照组(16.67%);P<0.01或<0.001。结论宫颈康凝胶对HPV感染疗效确切,适合临床抗HPV感染应用。 Objective Clinical observation of cervical infection Kang gel combined treatment of cervicitis human papil omavirus(HPV).Methods Choice of gynecological clinic diagnosed in our hospital cervicitis and 125 patients with HPV infection, were divided into three groups according to randomized double blind, cervical Kang group(50 cases)with cervical Kang gel;Baofukang group(45 cases)with Baofukang gel:blank control group(30 cases)using a blank gel were vaginal delivery treatment, results were statistical y analyzed.Results Effectofanti-HPV:GJKG(82.00%)〉Baofukang (71.11%)〉placebo(13.33%);cohort of clinical ef iciency on Cervicitis:GJKG(84.00%)〉Baofukang (68.89%)〉placebo (16.67%).P〈0.01 or 〈0.001,showing high or very high statistical significance. Conclusions GJKG has anti-HPV infection,suitable for clinical application.
出处 《中国药物经济学》 2014年第4期38-40,共3页 China Journal of Pharmaceutical Economics
基金 广东省中医药局科研课题(20120106)
关键词 中药 宫颈康凝胶 宫颈炎 人乳头瘤病毒 临床研究 Chinese medicine Gongjingkang gel(GJKG) Cervicitis Human Papillomavirus (HPV) Clinical study
  • 相关文献

参考文献9

二级参考文献59

  • 1商宇红,白丽霞,魏丽惠.中药保妇康栓对宫颈癌细胞抑制作用的分子机制研究[J].中国妇产科临床杂志,2003,4(5):336-338. 被引量:152
  • 2张雅琴,张甦,邢建明,李剑英,程红玲,高金来.高危型HPV与TCT配合阴道镜检查在宫颈病变中的诊断价值[J].实验与检验医学,2007,25(6):557-558. 被引量:5
  • 3钱德英,岑坚敏,王丁,曾仁海,林爱华,舒焰红,洪淡华,黄志宏.高危型人乳头状瘤病毒DNA检测与细胞学联合检查对子宫颈癌前病变筛查的研究[J].中华妇产科杂志,2006,41(1):34-37. 被引量:168
  • 4肖静,黄健.对高危型HPV治疗的研究进展[J].现代预防医学,2007,34(8):1464-1465. 被引量:14
  • 5Syrjanen S,Shabalova IP,Petrovichev N,et al.Human papillomavirus testing and conventional Pap smear cytology as optional screening tools of women at different risks for cervical cancer in Countries of the former Soviet Union.J Low Genit Tract Dis,2002,6:97-110.
  • 6Bosch FX,Manos MM,Munoz N,et al.Prevalence of human papillomavirus in cervical cancer:a worldwide perspective.International biological study on cervical cancer (IBSCC) Study Group.J Natl Cancer Inst,1995,87:796-802.
  • 7Vizcaino AP,Moreno V,Bosch FX,et al.International trends in incidence of cervical cancer:Ⅱ.Squamous-cell carcinoma.Int J Cancer,2000,86:429-435.
  • 8Munoz N,Bosch FX,de Sanjose S,et al.Epidemiologic classification of human papillomavirus types associated with cervical cancer.N Engl J Med,2003,348:518-527.
  • 9Clavel C,Masure M,Bory JP,et al.Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions:a study of 7932 women.Br J Cancer,2001,84:1616-1623.
  • 10Blumenthal PD,Gaffikin L,Chirenje ZM,et al.Adjunctive testing for cervical cancer in low resource settings with visual inspection,HPV,and the Pap smear.Int J Gynaecol Obstet,2001,72:47-53.

共引文献258

同被引文献55

引证文献4

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部